Tempus AI TEM rose on Wednesday after the company unveiled its new HRD-RNA algorithm, an AI-driven tool designed to improve detection of homologous recombination deficiency (HRD) in tumors. The ...

Tempus HRD-RNA is an AI-driven, 1,660-gene logistic regression model designed to identify patients likely to respond to ...

Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 3.5% Wednesday after the precision medicine technology company announced the launch of its new HRD-RNA algorithm for cancer detection.

A virus that is big enough to be seen under an ordinary light microscope co-opt its host’s systems with the help of ...

In the oceans and on land, scientists are discovering rare, transitional organisms that bridge the gap between Earth’s simplest cells and today’s complex ones.

With the exception of infectious diseases, examination of the environmental causes of illness has been piecemeal. Gary Miller, a toxicologist at Columbia University who also addressed the meeting, ...

The brain's ability to do everything from forming memories to coordinating movement relies on its cells producing the right proteins at the right time. But directly measuring this protein production, ...

The brain's ability to carry out everything from forming memories to coordinating movement depends on its cells producing the right proteins at the right time. But directly measuring this protein ...

After decades, scientists have finally pieced together the 23-step biosynthetic pathway to produce this cancer drug ...